1. Home
  2. RZLT vs DBI Comparison

RZLT vs DBI Comparison

Compare RZLT & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • DBI
  • Stock Information
  • Founded
  • RZLT 2010
  • DBI 1991
  • Country
  • RZLT United States
  • DBI United States
  • Employees
  • RZLT N/A
  • DBI N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • DBI Clothing/Shoe/Accessory Stores
  • Sector
  • RZLT Health Care
  • DBI Consumer Discretionary
  • Exchange
  • RZLT Nasdaq
  • DBI Nasdaq
  • Market Cap
  • RZLT 292.0M
  • DBI 292.2M
  • IPO Year
  • RZLT N/A
  • DBI 1991
  • Fundamental
  • Price
  • RZLT $5.01
  • DBI $5.70
  • Analyst Decision
  • RZLT Strong Buy
  • DBI Hold
  • Analyst Count
  • RZLT 8
  • DBI 2
  • Target Price
  • RZLT $11.63
  • DBI $5.75
  • AVG Volume (30 Days)
  • RZLT 388.2K
  • DBI 2.0M
  • Earning Date
  • RZLT 02-11-2025
  • DBI 12-10-2024
  • Dividend Yield
  • RZLT N/A
  • DBI 3.61%
  • EPS Growth
  • RZLT N/A
  • DBI N/A
  • EPS
  • RZLT N/A
  • DBI N/A
  • Revenue
  • RZLT N/A
  • DBI $3,050,038,000.00
  • Revenue This Year
  • RZLT N/A
  • DBI N/A
  • Revenue Next Year
  • RZLT N/A
  • DBI $2.23
  • P/E Ratio
  • RZLT N/A
  • DBI N/A
  • Revenue Growth
  • RZLT N/A
  • DBI N/A
  • 52 Week Low
  • RZLT $0.90
  • DBI $4.36
  • 52 Week High
  • RZLT $6.19
  • DBI $11.57
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 55.17
  • DBI 52.26
  • Support Level
  • RZLT $4.07
  • DBI $5.18
  • Resistance Level
  • RZLT $4.64
  • DBI $6.21
  • Average True Range (ATR)
  • RZLT 0.36
  • DBI 0.45
  • MACD
  • RZLT 0.01
  • DBI -0.03
  • Stochastic Oscillator
  • RZLT 67.14
  • DBI 61.64

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

About DBI Designer Brands Inc.

Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.

Share on Social Networks: